JP2021534165A5 - - Google Patents
Info
- Publication number
- JP2021534165A5 JP2021534165A5 JP2021507775A JP2021507775A JP2021534165A5 JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5 JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021507775 A JP2021507775 A JP 2021507775A JP 2021534165 A5 JP2021534165 A5 JP 2021534165A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- months
- antibody
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862765093P | 2018-08-16 | 2018-08-16 | |
| US62/765,093 | 2018-08-16 | ||
| PCT/US2019/046467 WO2020037024A1 (en) | 2018-08-16 | 2019-08-14 | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021534165A JP2021534165A (ja) | 2021-12-09 |
| JP2021534165A5 true JP2021534165A5 (cg-RX-API-DMAC7.html) | 2022-08-12 |
Family
ID=69525825
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507775A Pending JP2021534165A (ja) | 2018-08-16 | 2019-08-14 | 抗組織因子抗体−薬物コンジュゲートおよびがんの治療におけるその使用 |
Country Status (13)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI841554B (zh) | 2018-03-21 | 2024-05-11 | 丹麥商珍美寶股份有限公司 | 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法 |
| TW202506732A (zh) | 2018-05-07 | 2025-02-16 | 丹麥商珍美寶股份有限公司 | 使用抗ｐｄ－１抗體與抗組織因子抗體－藥物共軛體之組合以治療癌症之方法 |
| TWI844571B (zh) | 2018-10-30 | 2024-06-11 | 丹麥商珍美寶股份有限公司 | 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法 |
| CN115348971A (zh) * | 2020-03-30 | 2022-11-15 | 国立研究开发法人国立癌症研究中心 | 抗体-药物缀合物 |
| EP3919077A1 (en) | 2020-06-04 | 2021-12-08 | BioInvent International AB | Model for prediction of tolerability issues in connection with intravenous administration of therapeutic antibodies |
| WO2021245238A1 (en) | 2020-06-04 | 2021-12-09 | Bioinvent International Ab | Improving antibody tolerability associated with intravenous administration |
| BR112023018676A2 (pt) | 2021-03-18 | 2023-10-10 | Seagen Inc | Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA109633C2 (uk) * | 2008-12-09 | 2015-09-25 | Антитіло людини проти тканинного фактора | |
| BR112012031727B1 (pt) * | 2010-06-15 | 2022-03-29 | Genmab A/S | Conjugado de droga-anticorpo, composição farmacêutica, e, uso do conjugado de droga- anticorpo |
| SI3071237T1 (sl) * | 2013-11-21 | 2024-11-29 | Genmab A/S | Liofilizirana formulacija konjugata protitelo-zdravilo |
| SG11201609372UA (en) * | 2014-05-22 | 2016-12-29 | Synthon Biopharmaceuticals Bv | Site-specific conjugation of linker drugs to antibodies and resulting adcs |
| PT3347054T (pt) * | 2015-09-11 | 2021-07-15 | Genmab As | Regimes de dosagem para conjugados fármaco-anticorpo anti-tf |
| EA202090741A1 (ru) * | 2017-11-02 | 2020-07-30 | Генмаб А/С | Конъюгаты антитела к тканевому фактору и лекарственного средства и их применение в лечении рака |
| MX2020007077A (es) * | 2018-01-04 | 2020-10-28 | Iconic Therapeutics Inc | Anticuerpos anti-factor tisular, conjugados anticuerpo-farmaco y metodos relacionados. |
-
2019
- 2019-08-14 MX MX2021001058A patent/MX2021001058A/es unknown
- 2019-08-14 KR KR1020217007245A patent/KR20210046016A/ko not_active Withdrawn
- 2019-08-14 BR BR112021001691-0A patent/BR112021001691A2/pt unknown
- 2019-08-14 AU AU2019321442A patent/AU2019321442A1/en not_active Abandoned
- 2019-08-14 WO PCT/US2019/046467 patent/WO2020037024A1/en not_active Ceased
- 2019-08-14 CA CA3109116A patent/CA3109116A1/en active Pending
- 2019-08-14 JP JP2021507775A patent/JP2021534165A/ja active Pending
- 2019-08-14 CN CN201980054479.8A patent/CN112584872A/zh active Pending
- 2019-08-14 SG SG11202101428UA patent/SG11202101428UA/en unknown
- 2019-08-14 EP EP19849100.3A patent/EP3836950A4/en not_active Withdrawn
- 2019-08-14 EA EA202190102A patent/EA202190102A1/ru unknown
- 2019-08-14 US US17/268,387 patent/US20210308208A1/en not_active Abandoned
-
2021
- 2021-02-03 IL IL280617A patent/IL280617A/en unknown